Archive

Post Archive: Physicians

Virginia Cancer Specialists » VCS Practice News » Physicians » Page 5

Alex Spira, MD PhD FACP VCS Co-Author Virginia Cancer Specialists - JAMA Network - Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas Clinical Trial

Alex Spira MD PhD FACP, Clinical Trials and Research, The Sarcoma Center, Sarcoma
April 9, 2020
Read More

Felasfa Wodajo MD, Surgeon Virginia Cancer Specialists helps a patient with a rare condition. Washington Post

Musculoskeletal Tumor Surgery, Felasfa M. Wodajo MD
February 24, 2020
Read More

Lung Cancer Screening & Treatment Options Learn more from our cancer care experts, Dr. Christina Brzezniak Panelist

Christina Brzezniak DO, Lung Cancer
November 8, 2019
Read More

Sarcoma Awareness Month July 2019

Felasfa M. Wodajo MD, Sarcoma
July 30, 2019
Read More

New Treatments, New Hope for Bladder Cancer Patients at Virginia Cancer Specialists – Dr. Daniel Chong, MD

Bladder Cancer, Clinical Trials Search, Clinical Trials and Research, Daniel Chong MD
May 9, 2019
Read More

Fighting Brain Cancer at Virginia Cancer Specialists VCS:  Better Options, Better Outcomes -  Timothy A. McCarthy, MD

Brain Cancer, Clinical Trials Search, Brain Tumors, Clinical Trials and Research, Timothy A. McCarthy MD
April 30, 2019
Read More

3D Printing in Orthopaedic Surgery, Felasfa M. Wodajo, M.D. Musculoskeletal Tumor Surgeon Sarcoma Center

Felasfa M. Wodajo MD, The Sarcoma Center, Sarcoma
April 16, 2019
Read More

Alexander Spira, MD, PhD, FACP, on the recent approval of atezolizumab in SCLC

Alex Spira MD PhD FACP, Lung Cancer
April 2, 2019
Read More

Keeran Sampat MD on ABC7 WJLA News, Pancreatic Cancer Alex Trebek

Prostate Cancer, Keeran R. Sampat MD
March 14, 2019
Read More

Virginia Cancer Specialists (VCS) Now Offering a Newly FDA-Approved Targeted Therapy for Acute Leukemia

Alex Spira MD PhD FACP, Clinical Trials and Research, Leukemia, Hematology and Blood Cancers, Dipti Patel-Donnelly MD
February 4, 2019
Read More
Return to Top